Authors:
SHARPSTONE D
ROWBOTTOM A
FRANCIS N
TOVEY G
ELLIS D
BARRETT M
GAZZARD B
Citation: D. Sharpstone et al., THALIDOMINE - A NOVEL THERAPY FOR MICROSPORIDIOSIS (VOL 112, PG 1823,1997), Gastroenterology, 113(3), 1997, pp. 1054-1054
Authors:
SHARPSTONE D
ROWBOTTOM A
NELSON M
GAZZARD B
Citation: D. Sharpstone et al., FECAL ALPHA(1) ANTITRYPSIN AS A MARKER OF GASTROINTESTINAL-DISEASE INHIV ANTIBODY-POSITIVE INDIVIDUALS, Gut, 38(2), 1996, pp. 206-210
Authors:
KNECHTLI C
GOULDEN N
GARLAND R
HANCOCK J
ROWBOTTOM A
STEWARD C
POTTER M
OAKHILL A
Citation: C. Knechtli et al., THE VALUE OF MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) FOR THE PREDICTION OF RELAPSE AFTER BMT, British Journal of Haematology, 93, 1996, pp. 43-43
Authors:
GARLAND R
GOULDEN N
KNECHTLI C
LANGLANDS K
HANCOCK J
HIBBERT E
FERRIS V
ROWBOTTOM A
STEWARD C
POTTER M
OAKHILL A
Citation: R. Garland et al., ANALYSIS OF MINIMAL RESIDUAL DISEASE PREDICTS RELAPSE IN CHILDREN WITH STANDARD RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), British Journal of Haematology, 93, 1996, pp. 202-202
Authors:
EUSTACE D
HAN X
GOODING R
ROWBOTTOM A
RICHES P
HEYDERMAN E
Citation: D. Eustace et al., INTERLEUKIN-6 (IL-6) FUNCTIONS AS AN AUTOCRINE GROWTH-FACTOR IN CERVICAL CARCINOMAS IN-VITRO, Gynecologic oncology, 50(1), 1993, pp. 15-19